We continue our nibbling in YTLREIT as it is a very good yield trust as of now. Good hedging portfolio with hotels in different region. We start to hold Hovid also but we recommend buy slow on weakness. A few securities houses recommended Hovid and we reviewed the counter. We do agree as pharmaceutical company as of current trading PE is cheap. Good grow potential and we recommended a slow long term buy.
We also added MNRB slowly. May be MAS incident may impact MNRB insurance payment. But in long run we still like MNRB as a favourite.